COSMOS Pharma, First Half Ordinary Profit Increases by 26%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Jan 10, 2025 3:30 pm JST Earnings

3349 COSMOS Pharmaceutical Corporation 【J-GAAP】

Earnings Report

COSMOS Pharmaceutical Corporation <3349> [TSE Prime] announced its financial results after the market closed on January 10th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending May 2025 (June to November) increased 25.5% from the same period last year, reaching 21.7 billion yen, exceeded the previous forecast of 17.4 billion yen.

The progress rate toward the full-year plan of 34.4 billion yen was 63.3%, also surpassing the five-year average of 49.6%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the December to May period (2H) is expected to decrease 25.5% from the same period last year to 12.6 billion yen.

In the most recent three-month period, from September to November (2Q), the consolidated ordinary profit grew 24.0% from the same period last year, reaching 9.48 billion yen. The operating profit margin improved from 2.9% in the same period last year to 3.6%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Nov, 2022	404,016	15,385	16,900	11,299	142.7	51.1	Jan 13, 2023	J-GAAP
Jun - Nov, 2023	476,430	15,836	17,346	11,587	146.3	50.6	Jan 12, 2024	J-GAAP
Jun - Nov, 2024	505,936	20,344	21,777	14,428	182.1	63.3	Jan 10, 2025	J-GAAP
YoY	+6.2%	+28.5%	+25.5%	+24.5%	+24.5%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2024 Guidance	515,200	16,000	17,470	11,790	148.8	32.50	Jul 12, 2024	J-GAAP
Jun - Nov, 2024 Results	505,936	20,344	21,777	14,428	182.1	32.50	Jan 10, 2025	J-GAAP
Revision Rate	-1.8%	+27.2%	+24.7%	+22.4%	+22.4%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec - May, 2023	488,559	15,665	16,953	12,867	162.4	30	Jul 12, 2024	J-GAAP
Dec - May, 2024 Guidance	531,064	11,256	12,623	10,072	127.1	32.50	Jan 10, 2025	J-GAAP
YoY	+8.7%	-28.1%	-25.5%	-21.7%	-21.7%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2023	827,697	30,128	33,086	23,797	300.5	50	Jul 10, 2023	J-GAAP
May, 2024	964,989	31,501	34,299	24,454	308.6	60	Jul 12, 2024	J-GAAP
May, 2025 Guidance	1,037,000	31,600	34,400	24,500	309.1	65	Jul 12, 2024	J-GAAP
YoY	+7.5%	+0.3%	+0.3%	+0.2%	+0.2%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Sep - Nov, 2023	234,777	6,846	7,647	5,079	64.1	2.9	Jan 12, 2024	J-GAAP
Dec - Feb, 2023	238,881	7,902	8,568	5,770	72.8	3.3	Apr 12, 2024	J-GAAP
Mar - May, 2024	249,678	7,763	8,385	7,097	89.6	3.1	Jul 12, 2024	J-GAAP
Jun - Aug, 2024	261,841	11,580	12,293	8,143	102.7	4.4	Oct 11, 2024	J-GAAP
Sep - Nov, 2024	244,095	8,764	9,484	6,285	79.3	3.6	Jan 10, 2025	J-GAAP
YoY	+4.0%	+28.0%	+24.0%	+23.7%	+23.7%